# Histological, ultrastructural, and single-cell profiling reveal immune-mediated remodeling in gallbladder inflammation

**Authors:** Dmytro Vlasenko, Andrea Maccagno, Adriano Sanna, Tamara Papadakis, Shanjid Ahmed Shiplu, Ramona Schmid, Ulrich Gärtner, Bruno Märkl, Marco Koch, Maryam Keshavarz

PMC · DOI: 10.1007/s00441-026-04057-6 · Cell and Tissue Research · 2026-03-05

## TL;DR

This study identifies distinct immune and tissue changes in acute and chronic gallbladder inflammation using multiple analytical techniques.

## Contribution

The study reveals coordinated immune-stromal programs in acute and chronic gallbladder inflammation through multi-modal profiling.

## Key findings

- Acute cholecystitis features neutrophil and macrophage infiltration with epithelial disruption and systemic inflammation.
- Chronic cholelithiasis shows preserved epithelium, fibrosis, and macrophage-B-cell-fibroblast networks linked to fibrotic remodeling.
- Single-cell RNA sequencing identified twelve immune and stromal populations with distinct inflammatory profiles.

## Abstract

Gallbladder inflammation comprises distinct pathological entities, including acute, neutrophil-dominated injury and chronic, fibrotic remodeling. This study aimed to define the cellular and structural programs that characterize these two inflammatory states and link epithelial, immune, and stromal alterations. Tissue and blood samples from forty-one patients, including twelve with acute cholecystitis and twenty-nine with chronic cholelithiasis, were analyzed using histopathology, immunohistochemistry, transmission electron microscopy, targeted cytokine expression analysis, and single-cell RNA sequencing of immune-enriched suspensions. Acute cholecystitis showed epithelial disruption, edema, and dense infiltration by neutrophils and macrophages, including an increased density of CD163+ macrophages, accompanied by elevated systemic inflammation. Chronic cholelithiasis displayed preserved epithelial continuity, fibrosis, glandular remodeling, and reduced immune-cell density. Ultrastructural analysis revealed abundant mucin granules and intact junctions in acute inflammation, contrasting with mucin depletion and dense-body accumulation in chronic disease. Single-cell transcriptomic analysis identified twelve immune and stromal populations, showing contrasting immune–stromal configurations: pro-inflammatory myeloid and cytotoxic T cells dominated in acute inflammation, whereas macrophage–B-cell–fibroblast networks were enriched in chronic cholelithiasis, reflecting adaptive and fibrotic remodeling rather than a temporal transition. This study defines distinct but coordinated immune–stromal programs underlying human gallbladder inflammation and provides a cellular framework for understanding condition-specific mechanisms of acute and chronic disease.

## Linked entities

- **Proteins:** CD163 (CD163 molecule)
- **Diseases:** acute cholecystitis (MONDO:0002155)

## Full-text entities

- **Genes:** GPT (glutamic--pyruvic transaminase) [NCBI Gene 2875] {aka AAT1, ALT, ALT1, GPT1, SGPT}, IGKC (immunoglobulin kappa constant) [NCBI Gene 3514] {aka HCAK1, IGKCD, Km}, MUC4 (mucin 4, cell surface associated) [NCBI Gene 4585] {aka ASGP, HSA276359, MUC-4}, CXCL8 (C-X-C motif chemokine ligand 8) [NCBI Gene 3576] {aka GCP-1, GCP1, IL8, LECT, LUCT, LYNAP}, Muc4 (mucin 4) [NCBI Gene 140474] {aka 4933405I11Rik, Asgp}, Ema (electrophoretic mobility and agglutinibility) [NCBI Gene 107924], LUM (lumican) [NCBI Gene 4060] {aka LDC, SLRR2D}, Mucin [NCBI Gene 100508689], CIITA (class II major histocompatibility complex transactivator) [NCBI Gene 4261] {aka C2TA, CIITAIV, MHC2D1, MHC2TA, NLRA}, Krt18 (keratin 18) [NCBI Gene 16668] {aka CK18, K18, Krt1-18}, MUC5B (mucin 5B, oligomeric mucus/gel-forming) [NCBI Gene 727897] {aka MG1, MUC-5B, MUC5, MUC9}, IL10 (interleukin 10) [NCBI Gene 3586] {aka CSIF, GVHDS, IL-10, IL10A, TGIF}, S100A8 (S100 calcium binding protein A8) [NCBI Gene 6279] {aka 60B8AG, CAGA, CFAG, CGLA, CP-10, L1Ag}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, JCHAIN (joining chain of multimeric IgA and IgM) [NCBI Gene 3512] {aka IGCJ, IGJ, JCH}, GGTLC5P (gamma-glutamyltransferase light chain 5 pseudogene) [NCBI Gene 653590] {aka GGT}, Krt19 (keratin 19) [NCBI Gene 16669] {aka CK-19, EndoC, K19, Krt-1.19, Krt1-19}, HLA-DRA (major histocompatibility complex, class II, DR alpha) [NCBI Gene 3122] {aka HLA-DRA1}, MUC2 (mucin 2, oligomeric mucus/gel-forming) [NCBI Gene 4583] {aka MLP, MUC-2, SMUC}, C1QA (complement C1q A chain) [NCBI Gene 712] {aka C1QD1}, CD163 (CD163 molecule) [NCBI Gene 9332] {aka M130, MM130, SCARI1}, B2M (beta-2-microglobulin) [NCBI Gene 567] {aka AMYLD6, IMD43, MHC1D4}, CD79A (CD79a molecule) [NCBI Gene 973] {aka IGA, IGAlpha, MB-1, MB1}, IL1B (interleukin 1 beta) [NCBI Gene 3553] {aka IL-1, IL1-BETA, IL1F2, IL1beta}, Cd68 (CD68 antigen) [NCBI Gene 12514] {aka Lamp4, Scard1, gp110}, VDR (vitamin D receptor) [NCBI Gene 7421] {aka NR1I1, PPP1R163}, GNLY (granulysin) [NCBI Gene 10578] {aka D2S69E, LAG-2, LAG2, NKG5, TLA519}, CXCL13 (C-X-C motif chemokine ligand 13) [NCBI Gene 10563] {aka ANGIE, ANGIE2, BCA-1, BCA1, BLC, BLR1L}, Muc1 (mucin 1, transmembrane) [NCBI Gene 17829] {aka CD227, EMA, Muc-1}, CD74 (CD74 molecule) [NCBI Gene 972] {aka CLIP, DHLAG, HLADG, II, Ia-GAMMA, p33}, HLA-G (major histocompatibility complex, class I, G) [NCBI Gene 3135] {aka MHC-G}, MUC1 (mucin 1, cell surface associated) [NCBI Gene 4582] {aka ADMCKD, ADMCKD1, ADTKD2, CA 15-3, CD227, Ca15-3}, Fut4 (fucosyltransferase 4) [NCBI Gene 14345] {aka CD15, FAL, FucT-IV, LeX, SSEA-1, Ssea1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CSF1R (colony stimulating factor 1 receptor) [NCBI Gene 1436] {aka BANDDOS, C-FMS, CD115, CSF-1R, CSFR, FIM2}, Cd163 (CD163 antigen) [NCBI Gene 93671] {aka CD163v2, CD163v3}, GGT1 (gamma-glutamyltransferase 1) [NCBI Gene 2678] {aka CD224, D22S672, D22S732, GGT, GGT 1, GGTD}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, EPCAM (epithelial cell adhesion molecule) [NCBI Gene 4072] {aka Ber-Ep4, BerEp4, DIAR5, EGP-2, EGP314, EGP40}, IFNG (interferon gamma) [NCBI Gene 3458] {aka IFG, IFI, IMD69}, AREG (amphiregulin) [NCBI Gene 374] {aka AR, AREGB, CRDGF, SDGF}, SLC17A5 (solute carrier family 17 member 5) [NCBI Gene 26503] {aka AST, ISSD, NSD, SD, SIALIN, SIASD}, CRP (C-reactive protein) [NCBI Gene 1401] {aka PTX1}, PRF1 (perforin 1) [NCBI Gene 5551] {aka HPLH2, P1, PFP}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, NR1H4 (nuclear receptor subfamily 1 group H member 4) [NCBI Gene 9971] {aka BAR, FXR, HRR-1, HRR1, PFIC5, RIP14}, MZB1 (marginal zone B and B1 cell specific protein) [NCBI Gene 51237] {aka MEDA-7, PACAP, pERp1}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, NKG7 (natural killer cell granule protein 7) [NCBI Gene 4818] {aka GIG1, GMP-17, p15-TIA-1}, COL1A1 (collagen type I alpha 1 chain) [NCBI Gene 1277] {aka CAFYD, EDSARTH1, EDSC, OI1, OI2, OI3}, DCN (decorin) [NCBI Gene 1634] {aka CSCD, DSPG2, PG40, PGII, PGS2, SLRR1B}, FCGR3A (Fc gamma receptor IIIa) [NCBI Gene 2214] {aka CD16-II, CD16A, FCG3, FCGR3, FCRIIIA, FcGRIIIA}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CD14 (CD14 molecule) [NCBI Gene 929], GPBAR1 (G protein-coupled bile acid receptor 1) [NCBI Gene 151306] {aka BG37, GPCR19, GPR131, M-BAR, TGR5}
- **Diseases:** carcinogenesis (MESH:D063646), bile stasis (MESH:D014647), Gallbladder inflammation (MESH:D002764), jaundice (MESH:D007565), nausea (MESH:D009325), vomiting (MESH:D014839), bacterial cholangitis (MESH:D002761), acute and chronic disease (MESH:D000208), ischemia (MESH:D007511), dysplasia (MESH:D015792), Pain (MESH:D010146), gallbladder disease (MESH:D005705), fibrosis (MESH:D005355), Acute inflammation (MESH:D007249), abscess (MESH:D000038), atrophy (MESH:D001284), edema (MESH:D004487), hepatic and intestinal fibrosis (MESH:D008103), malignancies (MESH:D009369), gallstone (MESH:D042882), ischemic (MESH:D002545), Acute and chronic cholecystitis (MESH:D041881), Cystic-duct obstruction (MESH:D018297), biliary obstruction (MESH:D001658), tenderness (MESH:D063806), hepatitis (MESH:D056486), infectious diseases (MESH:D003141), autoimmune or immunodeficiency disorders (MESH:C580192), Chronic (MESH:D002908), tissue injury (MESH:D017695), disorder of the biliary system (MESH:D009422), necrosis (MESH:D009336), hyperplasia (MESH:D006965), Chronic cholelithiasis (MESH:D002769), HIV (MESH:D015658), epithelial injury (MESH:D009375), epithelial hyperplasia (MESH:D017573), macrophage (MESH:D055501), biliary dilatation (MESH:D015529), cholestatic (MESH:D002779), infection (MESH:D007239)
- **Chemicals:** acetylcholine (MESH:D000109), water (MESH:D014867), ethanol (MESH:D000431), osmium tetroxide (MESH:D009993), oxygen (MESH:D010100), paraffin (MESH:D010232), MgCl2 (MESH:D015636), EDTA (MESH:D004492), prostaglandins (MESH:D011453), bilirubin (MESH:D001663), xylene (MESH:D014992), agarose (MESH:D012685), lipid (MESH:D008055), SYBR Green (MESH:C098022), citrate (MESH:D019343), formalin (MESH:D005557), PBS (MESH:D007854), eosin (MESH:D004801), 3,3'-diaminobenzidine (MESH:D015100), KCl (MESH:D011189), Hematoxylin (MESH:D006416), H&amp;E (MESH:D006371), bile acid (MESH:D001647), hydrogen peroxide (MESH:D006861), OsO4 (-), uranyl acetate (MESH:C005460), leukotrienes (MESH:D015289)
- **Species:** Klebsiella (genus) [taxon 570], Enterococcus (genus) [taxon 1350], Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12960409/full.md

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12960409/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC12960409/full.md

---
Source: https://tomesphere.com/paper/PMC12960409